Jens-Peter Volkmer

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Ranjana H. Advani, Ian W. Flinn, Leslie Popplewell et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf, Nadine S. Jahchan, Peter J. Schnorr et al. · Journal of Clinical Investigation · 2016 · 431 citations · Full text

Medicine, Immunology, Oncology +13

An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells

Chad Tang, Andrew S. Lee, Jens-Peter Volkmer et al. · Nature Biotechnology · 2011 · 377 citations · Full text

Life Sciences, Biotechnology, Cell Biology +9

Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity

Nan Ring, Dietmar Herndler‐Brandstetter, Kipp Weiskopf et al. · Proceedings of the National Academy of Sciences · 2017 · 281 citations

Medicine, Immunology, Oncology +17